✉  info@marketresearchfuture.com   📞 +1 (855) 661-4441(US)   📞 +44 1720 412 167(UK)   📞 +91 2269738890(APAC)
Certified Global Research Member
Isomar 1 Iso 1
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Psychedelic Drugs Market Research Report By Application (Mental Health Treatment, Substance Abuse Treatment, Pain Management, End-of-Life Anxiety, Psychedelic-Assisted Therapy), By Drug Type (LSD, Psilocybin, MDMA, Ketamine, Ayahuasca), By Route of Administration (Oral, Intravenous, Intranasal, Sublingual, Inhalation), By End Use (Hospitals, Clinics, Research Institutions, Homecare) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa)- Forecast to 2035


ID: MRFR/HC/17701-HCR | 200 Pages | Author: Rahul Gotadki| April 2025

Psychedelic Drugs Market Segmentation




  • Psychedelic Drugs Market By Application (USD Billion, 2019-2035)




    • Mental Health Treatment




    • Substance Abuse Treatment




    • Pain Management




    • End-of-Life Anxiety




    • Psychedelic-Assisted Therapy








  • Psychedelic Drugs Market By Drug Type (USD Billion, 2019-2035)




    • LSD




    • Psilocybin




    • MDMA




    • Ketamine




    • Ayahuasca








  • Psychedelic Drugs Market By Route of Administration (USD Billion, 2019-2035)




    • Oral




    • Intravenous




    • Intranasal




    • Sublingual




    • Inhalation








  • Psychedelic Drugs Market By End Use (USD Billion, 2019-2035)




    • Hospitals




    • Clinics




    • Research Institutions




    • Homecare






 




  • Psychedelic Drugs Market By Regional (USD Billion, 2019-2035)




    • North America




    • Europe




    • South America




    • Asia Pacific




    • Middle East and Africa






 


Psychedelic Drugs Market Regional Outlook (USD Billion, 2019-2035)


 


 




  • North America Outlook (USD Billion, 2019-2035)




    • North America Psychedelic Drugs Market by Application Type




      • Mental Health Treatment




      • Substance Abuse Treatment




      • Pain Management




      • End-of-Life Anxiety




      • Psychedelic-Assisted Therapy






    • North America Psychedelic Drugs Market by Drug Type




      • LSD




      • Psilocybin




      • MDMA




      • Ketamine




      • Ayahuasca






    • North America Psychedelic Drugs Market by Route of Administration Type




      • Oral




      • Intravenous




      • Intranasal




      • Sublingual




      • Inhalation






    • North America Psychedelic Drugs Market by End Use Type




      • Hospitals




      • Clinics




      • Research Institutions




      • Homecare






    • North America Psychedelic Drugs Market by Regional Type




      • US




      • Canada






    • US Outlook (USD Billion, 2019-2035)




    • US Psychedelic Drugs Market by Application Type




      • Mental Health Treatment




      • Substance Abuse Treatment




      • Pain Management




      • End-of-Life Anxiety




      • Psychedelic-Assisted Therapy






    • US Psychedelic Drugs Market by Drug Type




      • LSD




      • Psilocybin




      • MDMA




      • Ketamine




      • Ayahuasca






    • US Psychedelic Drugs Market by Route of Administration Type




      • Oral




      • Intravenous




      • Intranasal




      • Sublingual




      • Inhalation






    • US Psychedelic Drugs Market by End Use Type




      • Hospitals




      • Clinics




      • Research Institutions




      • Homecare






    • CANADA Outlook (USD Billion, 2019-2035)




    • CANADA Psychedelic Drugs Market by Application Type




      • Mental Health Treatment




      • Substance Abuse Treatment




      • Pain Management




      • End-of-Life Anxiety




      • Psychedelic-Assisted Therapy






    • CANADA Psychedelic Drugs Market by Drug Type




      • LSD




      • Psilocybin




      • MDMA




      • Ketamine




      • Ayahuasca






    • CANADA Psychedelic Drugs Market by Route of Administration Type




      • Oral




      • Intravenous




      • Intranasal




      • Sublingual




      • Inhalation






    • CANADA Psychedelic Drugs Market by End Use Type




      • Hospitals




      • Clinics




      • Research Institutions




      • Homecare








  • Europe Outlook (USD Billion, 2019-2035)




    • Europe Psychedelic Drugs Market by Application Type




      • Mental Health Treatment




      • Substance Abuse Treatment




      • Pain Management




      • End-of-Life Anxiety




      • Psychedelic-Assisted Therapy






    • Europe Psychedelic Drugs Market by Drug Type




      • LSD




      • Psilocybin




      • MDMA




      • Ketamine




      • Ayahuasca






    • Europe Psychedelic Drugs Market by Route of Administration Type




      • Oral




      • Intravenous




      • Intranasal




      • Sublingual




      • Inhalation






    • Europe Psychedelic Drugs Market by End Use Type




      • Hospitals




      • Clinics




      • Research Institutions




      • Homecare






    • Europe Psychedelic Drugs Market by Regional Type




      • Germany




      • UK




      • France




      • Russia




      • Italy




      • Spain




      • Rest of Europe






    • GERMANY Outlook (USD Billion, 2019-2035)




    • GERMANY Psychedelic Drugs Market by Application Type




      • Mental Health Treatment




      • Substance Abuse Treatment




      • Pain Management




      • End-of-Life Anxiety




      • Psychedelic-Assisted Therapy






    • GERMANY Psychedelic Drugs Market by Drug Type




      • LSD




      • Psilocybin




      • MDMA




      • Ketamine




      • Ayahuasca






    • GERMANY Psychedelic Drugs Market by Route of Administration Type




      • Oral




      • Intravenous




      • Intranasal




      • Sublingual




      • Inhalation






    • GERMANY Psychedelic Drugs Market by End Use Type




      • Hospitals




      • Clinics




      • Research Institutions




      • Homecare






    • UK Outlook (USD Billion, 2019-2035)




    • UK Psychedelic Drugs Market by Application Type




      • Mental Health Treatment




      • Substance Abuse Treatment




      • Pain Management




      • End-of-Life Anxiety




      • Psychedelic-Assisted Therapy






    • UK Psychedelic Drugs Market by Drug Type




      • LSD




      • Psilocybin




      • MDMA




      • Ketamine




      • Ayahuasca






    • UK Psychedelic Drugs Market by Route of Administration Type




      • Oral




      • Intravenous




      • Intranasal




      • Sublingual




      • Inhalation






    • UK Psychedelic Drugs Market by End Use Type




      • Hospitals




      • Clinics




      • Research Institutions




      • Homecare






    • FRANCE Outlook (USD Billion, 2019-2035)




    • FRANCE Psychedelic Drugs Market by Application Type




      • Mental Health Treatment




      • Substance Abuse Treatment




      • Pain Management




      • End-of-Life Anxiety




      • Psychedelic-Assisted Therapy






    • FRANCE Psychedelic Drugs Market by Drug Type




      • LSD




      • Psilocybin




      • MDMA




      • Ketamine




      • Ayahuasca






    • FRANCE Psychedelic Drugs Market by Route of Administration Type




      • Oral




      • Intravenous




      • Intranasal




      • Sublingual




      • Inhalation






    • FRANCE Psychedelic Drugs Market by End Use Type




      • Hospitals




      • Clinics




      • Research Institutions




      • Homecare






    • RUSSIA Outlook (USD Billion, 2019-2035)




    • RUSSIA Psychedelic Drugs Market by Application Type




      • Mental Health Treatment




      • Substance Abuse Treatment




      • Pain Management




      • End-of-Life Anxiety




      • Psychedelic-Assisted Therapy






    • RUSSIA Psychedelic Drugs Market by Drug Type




      • LSD




      • Psilocybin




      • MDMA




      • Ketamine




      • Ayahuasca






    • RUSSIA Psychedelic Drugs Market by Route of Administration Type




      • Oral




      • Intravenous




      • Intranasal




      • Sublingual




      • Inhalation






    • RUSSIA Psychedelic Drugs Market by End Use Type




      • Hospitals




      • Clinics




      • Research Institutions




      • Homecare






    • ITALY Outlook (USD Billion, 2019-2035)




    • ITALY Psychedelic Drugs Market by Application Type




      • Mental Health Treatment




      • Substance Abuse Treatment




      • Pain Management




      • End-of-Life Anxiety




      • Psychedelic-Assisted Therapy






    • ITALY Psychedelic Drugs Market by Drug Type




      • LSD




      • Psilocybin




      • MDMA




      • Ketamine




      • Ayahuasca






    • ITALY Psychedelic Drugs Market by Route of Administration Type




      • Oral




      • Intravenous




      • Intranasal




      • Sublingual




      • Inhalation






    • ITALY Psychedelic Drugs Market by End Use Type




      • Hospitals




      • Clinics




      • Research Institutions




      • Homecare






    • SPAIN Outlook (USD Billion, 2019-2035)




    • SPAIN Psychedelic Drugs Market by Application Type




      • Mental Health Treatment




      • Substance Abuse Treatment




      • Pain Management




      • End-of-Life Anxiety




      • Psychedelic-Assisted Therapy






    • SPAIN Psychedelic Drugs Market by Drug Type




      • LSD




      • Psilocybin




      • MDMA




      • Ketamine




      • Ayahuasca






    • SPAIN Psychedelic Drugs Market by Route of Administration Type




      • Oral




      • Intravenous




      • Intranasal




      • Sublingual




      • Inhalation






    • SPAIN Psychedelic Drugs Market by End Use Type




      • Hospitals




      • Clinics




      • Research Institutions




      • Homecare






    • REST OF EUROPE Outlook (USD Billion, 2019-2035)




    • REST OF EUROPE Psychedelic Drugs Market by Application Type




      • Mental Health Treatment




      • Substance Abuse Treatment




      • Pain Management




      • End-of-Life Anxiety




      • Psychedelic-Assisted Therapy






    • REST OF EUROPE Psychedelic Drugs Market by Drug Type




      • LSD




      • Psilocybin




      • MDMA




      • Ketamine




      • Ayahuasca






    • REST OF EUROPE Psychedelic Drugs Market by Route of Administration Type




      • Oral




      • Intravenous




      • Intranasal




      • Sublingual




      • Inhalation






    • REST OF EUROPE Psychedelic Drugs Market by End Use Type




      • Hospitals




      • Clinics




      • Research Institutions




      • Homecare








  • APAC Outlook (USD Billion, 2019-2035)




    • APAC Psychedelic Drugs Market by Application Type




      • Mental Health Treatment




      • Substance Abuse Treatment




      • Pain Management




      • End-of-Life Anxiety




      • Psychedelic-Assisted Therapy






    • APAC Psychedelic Drugs Market by Drug Type




      • LSD




      • Psilocybin




      • MDMA




      • Ketamine




      • Ayahuasca






    • APAC Psychedelic Drugs Market by Route of Administration Type




      • Oral




      • Intravenous




      • Intranasal




      • Sublingual




      • Inhalation






    • APAC Psychedelic Drugs Market by End Use Type




      • Hospitals




      • Clinics




      • Research Institutions




      • Homecare






    • APAC Psychedelic Drugs Market by Regional Type




      • China




      • India




      • Japan




      • South Korea




      • Malaysia




      • Thailand




      • Indonesia




      • Rest of APAC






    • CHINA Outlook (USD Billion, 2019-2035)




    • CHINA Psychedelic Drugs Market by Application Type




      • Mental Health Treatment




      • Substance Abuse Treatment




      • Pain Management




      • End-of-Life Anxiety




      • Psychedelic-Assisted Therapy






    • CHINA Psychedelic Drugs Market by Drug Type




      • LSD




      • Psilocybin




      • MDMA




      • Ketamine




      • Ayahuasca






    • CHINA Psychedelic Drugs Market by Route of Administration Type




      • Oral




      • Intravenous




      • Intranasal




      • Sublingual




      • Inhalation






    • CHINA Psychedelic Drugs Market by End Use Type




      • Hospitals




      • Clinics




      • Research Institutions




      • Homecare






    • INDIA Outlook (USD Billion, 2019-2035)




    • INDIA Psychedelic Drugs Market by Application Type




      • Mental Health Treatment




      • Substance Abuse Treatment




      • Pain Management




      • End-of-Life Anxiety




      • Psychedelic-Assisted Therapy






    • INDIA Psychedelic Drugs Market by Drug Type




      • LSD




      • Psilocybin




      • MDMA




      • Ketamine




      • Ayahuasca






    • INDIA Psychedelic Drugs Market by Route of Administration Type




      • Oral




      • Intravenous




      • Intranasal




      • Sublingual




      • Inhalation






    • INDIA Psychedelic Drugs Market by End Use Type




      • Hospitals




      • Clinics




      • Research Institutions




      • Homecare






    • JAPAN Outlook (USD Billion, 2019-2035)




    • JAPAN Psychedelic Drugs Market by Application Type




      • Mental Health Treatment




      • Substance Abuse Treatment




      • Pain Management




      • End-of-Life Anxiety




      • Psychedelic-Assisted Therapy






    • JAPAN Psychedelic Drugs Market by Drug Type




      • LSD




      • Psilocybin




      • MDMA




      • Ketamine




      • Ayahuasca






    • JAPAN Psychedelic Drugs Market by Route of Administration Type




      • Oral




      • Intravenous




      • Intranasal




      • Sublingual




      • Inhalation






    • JAPAN Psychedelic Drugs Market by End Use Type




      • Hospitals




      • Clinics




      • Research Institutions




      • Homecare






    • SOUTH KOREA Outlook (USD Billion, 2019-2035)




    • SOUTH KOREA Psychedelic Drugs Market by Application Type




      • Mental Health Treatment




      • Substance Abuse Treatment




      • Pain Management




      • End-of-Life Anxiety




      • Psychedelic-Assisted Therapy






    • SOUTH KOREA Psychedelic Drugs Market by Drug Type




      • LSD




      • Psilocybin




      • MDMA




      • Ketamine




      • Ayahuasca






    • SOUTH KOREA Psychedelic Drugs Market by Route of Administration Type




      • Oral




      • Intravenous




      • Intranasal




      • Sublingual




      • Inhalation






    • SOUTH KOREA Psychedelic Drugs Market by End Use Type




      • Hospitals




      • Clinics




      • Research Institutions




      • Homecare






    • MALAYSIA Outlook (USD Billion, 2019-2035)




    • MALAYSIA Psychedelic Drugs Market by Application Type




      • Mental Health Treatment




      • Substance Abuse Treatment




      • Pain Management




      • End-of-Life Anxiety




      • Psychedelic-Assisted Therapy






    • MALAYSIA Psychedelic Drugs Market by Drug Type




      • LSD




      • Psilocybin




      • MDMA




      • Ketamine




      • Ayahuasca






    • MALAYSIA Psychedelic Drugs Market by Route of Administration Type




      • Oral




      • Intravenous




      • Intranasal




      • Sublingual




      • Inhalation






    • MALAYSIA Psychedelic Drugs Market by End Use Type




      • Hospitals




      • Clinics




      • Research Institutions




      • Homecare






    • THAILAND Outlook (USD Billion, 2019-2035)




    • THAILAND Psychedelic Drugs Market by Application Type




      • Mental Health Treatment




      • Substance Abuse Treatment




      • Pain Management




      • End-of-Life Anxiety




      • Psychedelic-Assisted Therapy






    • THAILAND Psychedelic Drugs Market by Drug Type




      • LSD




      • Psilocybin




      • MDMA




      • Ketamine




      • Ayahuasca






    • THAILAND Psychedelic Drugs Market by Route of Administration Type




      • Oral




      • Intravenous




      • Intranasal




      • Sublingual




      • Inhalation






    • THAILAND Psychedelic Drugs Market by End Use Type




      • Hospitals




      • Clinics




      • Research Institutions




      • Homecare






    • INDONESIA Outlook (USD Billion, 2019-2035)




    • INDONESIA Psychedelic Drugs Market by Application Type




      • Mental Health Treatment




      • Substance Abuse Treatment




      • Pain Management




      • End-of-Life Anxiety




      • Psychedelic-Assisted Therapy






    • INDONESIA Psychedelic Drugs Market by Drug Type




      • LSD




      • Psilocybin




      • MDMA




      • Ketamine




      • Ayahuasca






    • INDONESIA Psychedelic Drugs Market by Route of Administration Type




      • Oral




      • Intravenous




      • Intranasal




      • Sublingual




      • Inhalation






    • INDONESIA Psychedelic Drugs Market by End Use Type




      • Hospitals




      • Clinics




      • Research Institutions




      • Homecare






    • REST OF APAC Outlook (USD Billion, 2019-2035)




    • REST OF APAC Psychedelic Drugs Market by Application Type




      • Mental Health Treatment




      • Substance Abuse Treatment




      • Pain Management




      • End-of-Life Anxiety




      • Psychedelic-Assisted Therapy






    • REST OF APAC Psychedelic Drugs Market by Drug Type




      • LSD




      • Psilocybin




      • MDMA




      • Ketamine




      • Ayahuasca






    • REST OF APAC Psychedelic Drugs Market by Route of Administration Type




      • Oral




      • Intravenous




      • Intranasal




      • Sublingual




      • Inhalation






    • REST OF APAC Psychedelic Drugs Market by End Use Type




      • Hospitals




      • Clinics




      • Research Institutions




      • Homecare








  • South America Outlook (USD Billion, 2019-2035)




    • South America Psychedelic Drugs Market by Application Type




      • Mental Health Treatment




      • Substance Abuse Treatment




      • Pain Management




      • End-of-Life Anxiety




      • Psychedelic-Assisted Therapy






    • South America Psychedelic Drugs Market by Drug Type




      • LSD




      • Psilocybin




      • MDMA




      • Ketamine




      • Ayahuasca






    • South America Psychedelic Drugs Market by Route of Administration Type




      • Oral




      • Intravenous




      • Intranasal




      • Sublingual




      • Inhalation






    • South America Psychedelic Drugs Market by End Use Type




      • Hospitals




      • Clinics




      • Research Institutions




      • Homecare






    • South America Psychedelic Drugs Market by Regional Type




      • Brazil




      • Mexico




      • Argentina




      • Rest of South America






    • BRAZIL Outlook (USD Billion, 2019-2035)




    • BRAZIL Psychedelic Drugs Market by Application Type




      • Mental Health Treatment




      • Substance Abuse Treatment




      • Pain Management




      • End-of-Life Anxiety




      • Psychedelic-Assisted Therapy






    • BRAZIL Psychedelic Drugs Market by Drug Type




      • LSD




      • Psilocybin




      • MDMA




      • Ketamine




      • Ayahuasca






    • BRAZIL Psychedelic Drugs Market by Route of Administration Type




      • Oral




      • Intravenous




      • Intranasal




      • Sublingual




      • Inhalation






    • BRAZIL Psychedelic Drugs Market by End Use Type




      • Hospitals




      • Clinics




      • Research Institutions




      • Homecare






    • MEXICO Outlook (USD Billion, 2019-2035)




    • MEXICO Psychedelic Drugs Market by Application Type




      • Mental Health Treatment




      • Substance Abuse Treatment




      • Pain Management




      • End-of-Life Anxiety




      • Psychedelic-Assisted Therapy






    • MEXICO Psychedelic Drugs Market by Drug Type




      • LSD




      • Psilocybin




      • MDMA




      • Ketamine




      • Ayahuasca






    • MEXICO Psychedelic Drugs Market by Route of Administration Type




      • Oral




      • Intravenous




      • Intranasal




      • Sublingual




      • Inhalation






    • MEXICO Psychedelic Drugs Market by End Use Type




      • Hospitals




      • Clinics




      • Research Institutions




      • Homecare






    • ARGENTINA Outlook (USD Billion, 2019-2035)




    • ARGENTINA Psychedelic Drugs Market by Application Type




      • Mental Health Treatment




      • Substance Abuse Treatment




      • Pain Management




      • End-of-Life Anxiety




      • Psychedelic-Assisted Therapy






    • ARGENTINA Psychedelic Drugs Market by Drug Type




      • LSD




      • Psilocybin




      • MDMA




      • Ketamine




      • Ayahuasca






    • ARGENTINA Psychedelic Drugs Market by Route of Administration Type




      • Oral




      • Intravenous




      • Intranasal




      • Sublingual




      • Inhalation






    • ARGENTINA Psychedelic Drugs Market by End Use Type




      • Hospitals




      • Clinics




      • Research Institutions




      • Homecare






    • REST OF SOUTH AMERICA Outlook (USD Billion, 2019-2035)




    • REST OF SOUTH AMERICA Psychedelic Drugs Market by Application Type




      • Mental Health Treatment




      • Substance Abuse Treatment




      • Pain Management




      • End-of-Life Anxiety




      • Psychedelic-Assisted Therapy






    • REST OF SOUTH AMERICA Psychedelic Drugs Market by Drug Type




      • LSD




      • Psilocybin




      • MDMA




      • Ketamine




      • Ayahuasca






    • REST OF SOUTH AMERICA Psychedelic Drugs Market by Route of Administration Type




      • Oral




      • Intravenous




      • Intranasal




      • Sublingual




      • Inhalation






    • REST OF SOUTH AMERICA Psychedelic Drugs Market by End Use Type




      • Hospitals




      • Clinics




      • Research Institutions




      • Homecare








  • MEA Outlook (USD Billion, 2019-2035)




    • MEA Psychedelic Drugs Market by Application Type




      • Mental Health Treatment




      • Substance Abuse Treatment




      • Pain Management




      • End-of-Life Anxiety




      • Psychedelic-Assisted Therapy






    • MEA Psychedelic Drugs Market by Drug Type




      • LSD




      • Psilocybin




      • MDMA




      • Ketamine




      • Ayahuasca






    • MEA Psychedelic Drugs Market by Route of Administration Type




      • Oral




      • Intravenous




      • Intranasal




      • Sublingual




      • Inhalation






    • MEA Psychedelic Drugs Market by End Use Type




      • Hospitals




      • Clinics




      • Research Institutions




      • Homecare






    • MEA Psychedelic Drugs Market by Regional Type




      • GCC Countries




      • South Africa




      • Rest of MEA






    • GCC COUNTRIES Outlook (USD Billion, 2019-2035)




    • GCC COUNTRIES Psychedelic Drugs Market by Application Type




      • Mental Health Treatment




      • Substance Abuse Treatment




      • Pain Management




      • End-of-Life Anxiety




      • Psychedelic-Assisted Therapy






    • GCC COUNTRIES Psychedelic Drugs Market by Drug Type




      • LSD




      • Psilocybin




      • MDMA




      • Ketamine




      • Ayahuasca






    • GCC COUNTRIES Psychedelic Drugs Market by Route of Administration Type




      • Oral




      • Intravenous




      • Intranasal




      • Sublingual




      • Inhalation






    • GCC COUNTRIES Psychedelic Drugs Market by End Use Type




      • Hospitals




      • Clinics




      • Research Institutions




      • Homecare






    • SOUTH AFRICA Outlook (USD Billion, 2019-2035)




    • SOUTH AFRICA Psychedelic Drugs Market by Application Type




      • Mental Health Treatment




      • Substance Abuse Treatment




      • Pain Management




      • End-of-Life Anxiety




      • Psychedelic-Assisted Therapy






    • SOUTH AFRICA Psychedelic Drugs Market by Drug Type




      • LSD




      • Psilocybin




      • MDMA




      • Ketamine




      • Ayahuasca






    • SOUTH AFRICA Psychedelic Drugs Market by Route of Administration Type




      • Oral




      • Intravenous




      • Intranasal




      • Sublingual




      • Inhalation






    • SOUTH AFRICA Psychedelic Drugs Market by End Use Type




      • Hospitals




      • Clinics




      • Research Institutions




      • Homecare






    • REST OF MEA Outlook (USD Billion, 2019-2035)




    • REST OF MEA Psychedelic Drugs Market by Application Type




      • Mental Health Treatment




      • Substance Abuse Treatment




      • Pain Management




      • End-of-Life Anxiety




      • Psychedelic-Assisted Therapy






    • REST OF MEA Psychedelic Drugs Market by Drug Type




      • LSD




      • Psilocybin




      • MDMA




      • Ketamine




      • Ayahuasca






    • REST OF MEA Psychedelic Drugs Market by Route of Administration Type




      • Oral




      • Intravenous




      • Intranasal




      • Sublingual




      • Inhalation






    • REST OF MEA Psychedelic Drugs Market by End Use Type




      • Hospitals




      • Clinics




      • Research Institutions




      • Homecare








 


 

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Please fill in Business Email for Quick Response

Table of Contents




  1. EXECUTIVE SUMMARY




    1. Market Overview




    2. Key Findings




    3. Market Segmentation




    4. Competitive Landscape




    5. Challenges and Opportunities




    6. Future Outlook






 


 




  1. MARKET INTRODUCTION




    1. Definition




    2. Scope of the study




      1. Research Objective




      2. Assumption




      3. Limitations








  2. RESEARCH METHODOLOGY




    1. Overview




    2. Data Mining




    3. Secondary Research




    4. Primary Research




      1. Primary Interviews and Information Gathering Process




      2. Breakdown of Primary Respondents






    5. Forecasting Model




    6. Market Size Estimation




      1. Bottom-Up Approach




      2. Top-Down Approach






    7. Data Triangulation




    8. Validation






 


 




  1. MARKET DYNAMICS




    1. Overview




    2. Drivers




    3. Restraints




    4. Opportunities






  2. MARKET FACTOR ANALYSIS




    1. Value chain Analysis




    2. Porter's Five Forces Analysis




      1. Bargaining Power of Suppliers




      2. Bargaining Power of Buyers




      3. Threat of New Entrants




      4. Threat of Substitutes




      5. Intensity of Rivalry






    3. COVID-19 Impact Analysis




      1. Market Impact Analysis




      2. Regional Impact




      3. Opportunity and Threat Analysis








 


 




  1. Psychedelic Drugs Market, BY Application (USD Billion)




    1. Mental Health Treatment




    2. Substance Abuse Treatment




    3. Pain Management




    4. End-of-Life Anxiety




    5. Psychedelic-Assisted Therapy






  2. Psychedelic Drugs Market, BY Drug Type (USD Billion)




    1. LSD




    2. Psilocybin




    3. MDMA




    4. Ketamine




    5. Ayahuasca






  3. Psychedelic Drugs Market, BY Route of Administration (USD Billion)




    1. Oral




    2. Intravenous




    3. Intranasal




    4. Sublingual




    5. Inhalation






  4. Psychedelic Drugs Market, BY End Use (USD Billion)




    1. Hospitals




    2. Clinics




    3. Research Institutions




    4. Homecare






  5. Psychedelic Drugs Market, BY Regional (USD Billion)




    1. North America




      1. US




      2. Canada






    2. Europe




      1. Germany




      2. UK




      3. France




      4. Russia




      5. Italy




      6. Spain




      7. Rest of Europe






    3. APAC




      1. China




      2. India




      3. Japan




      4. South Korea




      5. Malaysia




      6. Thailand




      7. Indonesia




      8. Rest of APAC






    4. South America




      1. Brazil




      2. Mexico




      3. Argentina




      4. Rest of South America






    5. MEA




      1. GCC Countries




      2. South Africa




      3. Rest of MEA








 


 




  1. Competitive Landscape




    1. Overview




    2. Competitive Analysis




    3. Market share Analysis




    4. Major Growth Strategy in the Psychedelic Drugs Market




    5. Competitive Benchmarking




    6. Leading Players in Terms of Number of Developments in the Psychedelic Drugs Market




    7. Key developments and growth strategies




      1. New Product Launch/Service Deployment




      2. Merger & Acquisitions




      3. Joint Ventures






    8. Major Players Financial Matrix




      1. Sales and Operating Income




      2. Major Players R&D Expenditure. 2023








  2. Company Profiles




    1. Atai Life Sciences




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies






    2. Silo Wellness




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies






    3. Novamind




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies






    4. Osmind




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies






    5. Mind Medicine




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies






    6. Enthea




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies






    7. Psychedelics Today




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies






    8. Compass Pathways




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies






    9. Havn Life Sciences




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies






    10. Beckley Psytech




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies






    11. Numinus Wellness




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies






    12. Cybin




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies






    13. Dose Response




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies






    14. Field Trip Health




      1. Financial Overview




      2. Products Offered




      3. Key Developments




      4. SWOT Analysis




      5. Key Strategies








  3. Appendix




    1. References




    2. Related Reports






LIST Of tables


 




  1. LIST OF ASSUMPTIONS




  2. North America Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  3. North America Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  4. North America Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD Billions)




  5. North America Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)




  6. North America Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  7. US Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  8. US Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  9. US Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD Billions)




  10. US Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)




  11. US Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  12. Canada Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  13. Canada Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  14. Canada Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD Billions)




  15. Canada Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)




  16. Canada Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  17. Europe Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  18. Europe Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  19. Europe Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD Billions)




  20. Europe Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)




  21. Europe Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  22. Germany Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  23. Germany Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  24. Germany Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD Billions)




  25. Germany Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)




  26. Germany Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  27. UK Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  28. UK Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  29. UK Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD Billions)




  30. UK Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)




  31. UK Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  32. France Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  33. France Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  34. France Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD Billions)




  35. France Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)




  36. France Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  37. Russia Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  38. Russia Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  39. Russia Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD Billions)




  40. Russia Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)




  41. Russia Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  42. Italy Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  43. Italy Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  44. Italy Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD Billions)




  45. Italy Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)




  46. Italy Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  47. Spain Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  48. Spain Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  49. Spain Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD Billions)




  50. Spain Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)




  51. Spain Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  52. Rest of Europe Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  53. Rest of Europe Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  54. Rest of Europe Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD Billions)




  55. Rest of Europe Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)




  56. Rest of Europe Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  57. APAC Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  58. APAC Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  59. APAC Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD Billions)




  60. APAC Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)




  61. APAC Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  62. China Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  63. China Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  64. China Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD Billions)




  65. China Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)




  66. China Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  67. India Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  68. India Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  69. India Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD Billions)




  70. India Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)




  71. India Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  72. Japan Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  73. Japan Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  74. Japan Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD Billions)




  75. Japan Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)




  76. Japan Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  77. South Korea Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  78. South Korea Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  79. South Korea Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD Billions)




  80. South Korea Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)




  81. South Korea Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  82. Malaysia Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  83. Malaysia Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  84. Malaysia Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD Billions)




  85. Malaysia Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)




  86. Malaysia Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  87. Thailand Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  88. Thailand Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  89. Thailand Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD Billions)




  90. Thailand Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)




  91. Thailand Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  92. Indonesia Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  93. Indonesia Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  94. Indonesia Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD Billions)




  95. Indonesia Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)




  96. Indonesia Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  97. Rest of APAC Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  98. Rest of APAC Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  99. Rest of APAC Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD Billions)




  100. Rest of APAC Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)




  101. Rest of APAC Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  102. South America Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  103. South America Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  104. South America Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD Billions)




  105. South America Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)




  106. South America Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  107. Brazil Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  108. Brazil Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  109. Brazil Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD Billions)




  110. Brazil Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)




  111. Brazil Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  112. Mexico Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  113. Mexico Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  114. Mexico Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD Billions)




  115. Mexico Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)




  116. Mexico Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  117. Argentina Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  118. Argentina Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  119. Argentina Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD Billions)




  120. Argentina Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)




  121. Argentina Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  122. Rest of South America Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  123. Rest of South America Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  124. Rest of South America Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD Billions)




  125. Rest of South America Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)




  126. Rest of South America Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  127. MEA Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  128. MEA Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  129. MEA Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD Billions)




  130. MEA Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)




  131. MEA Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  132. GCC Countries Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  133. GCC Countries Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  134. GCC Countries Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD Billions)




  135. GCC Countries Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)




  136. GCC Countries Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  137. South Africa Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  138. South Africa Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  139. South Africa Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD Billions)




  140. South Africa Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)




  141. South Africa Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  142. Rest of MEA Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY APPLICATION, 2019-2035 (USD Billions)




  143. Rest of MEA Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY DRUG TYPE, 2019-2035 (USD Billions)




  144. Rest of MEA Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY ROUTE OF ADMINISTRATION, 2019-2035 (USD Billions)




  145. Rest of MEA Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY END USE, 2019-2035 (USD Billions)




  146. Rest of MEA Psychedelic Drugs Market SIZE ESTIMATES & FORECAST, BY REGIONAL, 2019-2035 (USD Billions)




  147. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL




  148. ACQUISITION/PARTNERSHIP




 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


 


LIST Of figures


 




  1. MARKET SYNOPSIS




  2. NORTH AMERICA PSYCHEDELIC DRUGS MARKET ANALYSIS




  3. US PSYCHEDELIC DRUGS MARKET ANALYSIS BY APPLICATION




  4. US PSYCHEDELIC DRUGS MARKET ANALYSIS BY DRUG TYPE




  5. US PSYCHEDELIC DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION




  6. US PSYCHEDELIC DRUGS MARKET ANALYSIS BY END USE




  7. US PSYCHEDELIC DRUGS MARKET ANALYSIS BY REGIONAL




  8. CANADA PSYCHEDELIC DRUGS MARKET ANALYSIS BY APPLICATION




  9. CANADA PSYCHEDELIC DRUGS MARKET ANALYSIS BY DRUG TYPE




  10. CANADA PSYCHEDELIC DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION




  11. CANADA PSYCHEDELIC DRUGS MARKET ANALYSIS BY END USE




  12. CANADA PSYCHEDELIC DRUGS MARKET ANALYSIS BY REGIONAL




  13. EUROPE PSYCHEDELIC DRUGS MARKET ANALYSIS




  14. GERMANY PSYCHEDELIC DRUGS MARKET ANALYSIS BY APPLICATION




  15. GERMANY PSYCHEDELIC DRUGS MARKET ANALYSIS BY DRUG TYPE




  16. GERMANY PSYCHEDELIC DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION




  17. GERMANY PSYCHEDELIC DRUGS MARKET ANALYSIS BY END USE




  18. GERMANY PSYCHEDELIC DRUGS MARKET ANALYSIS BY REGIONAL




  19. UK PSYCHEDELIC DRUGS MARKET ANALYSIS BY APPLICATION




  20. UK PSYCHEDELIC DRUGS MARKET ANALYSIS BY DRUG TYPE




  21. UK PSYCHEDELIC DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION




  22. UK PSYCHEDELIC DRUGS MARKET ANALYSIS BY END USE




  23. UK PSYCHEDELIC DRUGS MARKET ANALYSIS BY REGIONAL




  24. FRANCE PSYCHEDELIC DRUGS MARKET ANALYSIS BY APPLICATION




  25. FRANCE PSYCHEDELIC DRUGS MARKET ANALYSIS BY DRUG TYPE




  26. FRANCE PSYCHEDELIC DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION




  27. FRANCE PSYCHEDELIC DRUGS MARKET ANALYSIS BY END USE




  28. FRANCE PSYCHEDELIC DRUGS MARKET ANALYSIS BY REGIONAL




  29. RUSSIA PSYCHEDELIC DRUGS MARKET ANALYSIS BY APPLICATION




  30. RUSSIA PSYCHEDELIC DRUGS MARKET ANALYSIS BY DRUG TYPE




  31. RUSSIA PSYCHEDELIC DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION




  32. RUSSIA PSYCHEDELIC DRUGS MARKET ANALYSIS BY END USE




  33. RUSSIA PSYCHEDELIC DRUGS MARKET ANALYSIS BY REGIONAL




  34. ITALY PSYCHEDELIC DRUGS MARKET ANALYSIS BY APPLICATION




  35. ITALY PSYCHEDELIC DRUGS MARKET ANALYSIS BY DRUG TYPE




  36. ITALY PSYCHEDELIC DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION




  37. ITALY PSYCHEDELIC DRUGS MARKET ANALYSIS BY END USE




  38. ITALY PSYCHEDELIC DRUGS MARKET ANALYSIS BY REGIONAL




  39. SPAIN PSYCHEDELIC DRUGS MARKET ANALYSIS BY APPLICATION




  40. SPAIN PSYCHEDELIC DRUGS MARKET ANALYSIS BY DRUG TYPE




  41. SPAIN PSYCHEDELIC DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION




  42. SPAIN PSYCHEDELIC DRUGS MARKET ANALYSIS BY END USE




  43. SPAIN PSYCHEDELIC DRUGS MARKET ANALYSIS BY REGIONAL




  44. REST OF EUROPE PSYCHEDELIC DRUGS MARKET ANALYSIS BY APPLICATION




  45. REST OF EUROPE PSYCHEDELIC DRUGS MARKET ANALYSIS BY DRUG TYPE




  46. REST OF EUROPE PSYCHEDELIC DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION




  47. REST OF EUROPE PSYCHEDELIC DRUGS MARKET ANALYSIS BY END USE




  48. REST OF EUROPE PSYCHEDELIC DRUGS MARKET ANALYSIS BY REGIONAL




  49. APAC PSYCHEDELIC DRUGS MARKET ANALYSIS




  50. CHINA PSYCHEDELIC DRUGS MARKET ANALYSIS BY APPLICATION




  51. CHINA PSYCHEDELIC DRUGS MARKET ANALYSIS BY DRUG TYPE




  52. CHINA PSYCHEDELIC DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION




  53. CHINA PSYCHEDELIC DRUGS MARKET ANALYSIS BY END USE




  54. CHINA PSYCHEDELIC DRUGS MARKET ANALYSIS BY REGIONAL




  55. INDIA PSYCHEDELIC DRUGS MARKET ANALYSIS BY APPLICATION




  56. INDIA PSYCHEDELIC DRUGS MARKET ANALYSIS BY DRUG TYPE




  57. INDIA PSYCHEDELIC DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION




  58. INDIA PSYCHEDELIC DRUGS MARKET ANALYSIS BY END USE




  59. INDIA PSYCHEDELIC DRUGS MARKET ANALYSIS BY REGIONAL




  60. JAPAN PSYCHEDELIC DRUGS MARKET ANALYSIS BY APPLICATION




  61. JAPAN PSYCHEDELIC DRUGS MARKET ANALYSIS BY DRUG TYPE




  62. JAPAN PSYCHEDELIC DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION




  63. JAPAN PSYCHEDELIC DRUGS MARKET ANALYSIS BY END USE




  64. JAPAN PSYCHEDELIC DRUGS MARKET ANALYSIS BY REGIONAL




  65. SOUTH KOREA PSYCHEDELIC DRUGS MARKET ANALYSIS BY APPLICATION




  66. SOUTH KOREA PSYCHEDELIC DRUGS MARKET ANALYSIS BY DRUG TYPE




  67. SOUTH KOREA PSYCHEDELIC DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION




  68. SOUTH KOREA PSYCHEDELIC DRUGS MARKET ANALYSIS BY END USE




  69. SOUTH KOREA PSYCHEDELIC DRUGS MARKET ANALYSIS BY REGIONAL




  70. MALAYSIA PSYCHEDELIC DRUGS MARKET ANALYSIS BY APPLICATION




  71. MALAYSIA PSYCHEDELIC DRUGS MARKET ANALYSIS BY DRUG TYPE




  72. MALAYSIA PSYCHEDELIC DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION




  73. MALAYSIA PSYCHEDELIC DRUGS MARKET ANALYSIS BY END USE




  74. MALAYSIA PSYCHEDELIC DRUGS MARKET ANALYSIS BY REGIONAL




  75. THAILAND PSYCHEDELIC DRUGS MARKET ANALYSIS BY APPLICATION




  76. THAILAND PSYCHEDELIC DRUGS MARKET ANALYSIS BY DRUG TYPE




  77. THAILAND PSYCHEDELIC DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION




  78. THAILAND PSYCHEDELIC DRUGS MARKET ANALYSIS BY END USE




  79. THAILAND PSYCHEDELIC DRUGS MARKET ANALYSIS BY REGIONAL




  80. INDONESIA PSYCHEDELIC DRUGS MARKET ANALYSIS BY APPLICATION




  81. INDONESIA PSYCHEDELIC DRUGS MARKET ANALYSIS BY DRUG TYPE




  82. INDONESIA PSYCHEDELIC DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION




  83. INDONESIA PSYCHEDELIC DRUGS MARKET ANALYSIS BY END USE




  84. INDONESIA PSYCHEDELIC DRUGS MARKET ANALYSIS BY REGIONAL




  85. REST OF APAC PSYCHEDELIC DRUGS MARKET ANALYSIS BY APPLICATION




  86. REST OF APAC PSYCHEDELIC DRUGS MARKET ANALYSIS BY DRUG TYPE




  87. REST OF APAC PSYCHEDELIC DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION




  88. REST OF APAC PSYCHEDELIC DRUGS MARKET ANALYSIS BY END USE




  89. REST OF APAC PSYCHEDELIC DRUGS MARKET ANALYSIS BY REGIONAL




  90. SOUTH AMERICA PSYCHEDELIC DRUGS MARKET ANALYSIS




  91. BRAZIL PSYCHEDELIC DRUGS MARKET ANALYSIS BY APPLICATION




  92. BRAZIL PSYCHEDELIC DRUGS MARKET ANALYSIS BY DRUG TYPE




  93. BRAZIL PSYCHEDELIC DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION




  94. BRAZIL PSYCHEDELIC DRUGS MARKET ANALYSIS BY END USE




  95. BRAZIL PSYCHEDELIC DRUGS MARKET ANALYSIS BY REGIONAL




  96. MEXICO PSYCHEDELIC DRUGS MARKET ANALYSIS BY APPLICATION




  97. MEXICO PSYCHEDELIC DRUGS MARKET ANALYSIS BY DRUG TYPE




  98. MEXICO PSYCHEDELIC DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION




  99. MEXICO PSYCHEDELIC DRUGS MARKET ANALYSIS BY END USE




  100. MEXICO PSYCHEDELIC DRUGS MARKET ANALYSIS BY REGIONAL




  101. ARGENTINA PSYCHEDELIC DRUGS MARKET ANALYSIS BY APPLICATION




  102. ARGENTINA PSYCHEDELIC DRUGS MARKET ANALYSIS BY DRUG TYPE




  103. ARGENTINA PSYCHEDELIC DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION




  104. ARGENTINA PSYCHEDELIC DRUGS MARKET ANALYSIS BY END USE




  105. ARGENTINA PSYCHEDELIC DRUGS MARKET ANALYSIS BY REGIONAL




  106. REST OF SOUTH AMERICA PSYCHEDELIC DRUGS MARKET ANALYSIS BY APPLICATION




  107. REST OF SOUTH AMERICA PSYCHEDELIC DRUGS MARKET ANALYSIS BY DRUG TYPE




  108. REST OF SOUTH AMERICA PSYCHEDELIC DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION




  109. REST OF SOUTH AMERICA PSYCHEDELIC DRUGS MARKET ANALYSIS BY END USE




  110. REST OF SOUTH AMERICA PSYCHEDELIC DRUGS MARKET ANALYSIS BY REGIONAL




  111. MEA PSYCHEDELIC DRUGS MARKET ANALYSIS




  112. GCC COUNTRIES PSYCHEDELIC DRUGS MARKET ANALYSIS BY APPLICATION




  113. GCC COUNTRIES PSYCHEDELIC DRUGS MARKET ANALYSIS BY DRUG TYPE




  114. GCC COUNTRIES PSYCHEDELIC DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION




  115. GCC COUNTRIES PSYCHEDELIC DRUGS MARKET ANALYSIS BY END USE




  116. GCC COUNTRIES PSYCHEDELIC DRUGS MARKET ANALYSIS BY REGIONAL




  117. SOUTH AFRICA PSYCHEDELIC DRUGS MARKET ANALYSIS BY APPLICATION




  118. SOUTH AFRICA PSYCHEDELIC DRUGS MARKET ANALYSIS BY DRUG TYPE




  119. SOUTH AFRICA PSYCHEDELIC DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION




  120. SOUTH AFRICA PSYCHEDELIC DRUGS MARKET ANALYSIS BY END USE




  121. SOUTH AFRICA PSYCHEDELIC DRUGS MARKET ANALYSIS BY REGIONAL




  122. REST OF MEA PSYCHEDELIC DRUGS MARKET ANALYSIS BY APPLICATION




  123. REST OF MEA PSYCHEDELIC DRUGS MARKET ANALYSIS BY DRUG TYPE




  124. REST OF MEA PSYCHEDELIC DRUGS MARKET ANALYSIS BY ROUTE OF ADMINISTRATION




  125. REST OF MEA PSYCHEDELIC DRUGS MARKET ANALYSIS BY END USE




  126. REST OF MEA PSYCHEDELIC DRUGS MARKET ANALYSIS BY REGIONAL




  127. KEY BUYING CRITERIA OF PSYCHEDELIC DRUGS MARKET




  128. RESEARCH PROCESS OF MRFR




  129. DRO ANALYSIS OF PSYCHEDELIC DRUGS MARKET




  130. DRIVERS IMPACT ANALYSIS: PSYCHEDELIC DRUGS MARKET




  131. RESTRAINTS IMPACT ANALYSIS: PSYCHEDELIC DRUGS MARKET




  132. SUPPLY / VALUE CHAIN: PSYCHEDELIC DRUGS MARKET




  133. PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2025 (% SHARE)




  134. PSYCHEDELIC DRUGS MARKET, BY APPLICATION, 2019 TO 2035 (USD Billions)




  135. PSYCHEDELIC DRUGS MARKET, BY DRUG TYPE, 2025 (% SHARE)




  136. PSYCHEDELIC DRUGS MARKET, BY DRUG TYPE, 2019 TO 2035 (USD Billions)




  137. PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2025 (% SHARE)




  138. PSYCHEDELIC DRUGS MARKET, BY ROUTE OF ADMINISTRATION, 2019 TO 2035 (USD Billions)




  139. PSYCHEDELIC DRUGS MARKET, BY END USE, 2025 (% SHARE)




  140. PSYCHEDELIC DRUGS MARKET, BY END USE, 2019 TO 2035 (USD Billions)




  141. PSYCHEDELIC DRUGS MARKET, BY REGIONAL, 2025 (% SHARE)




  142. PSYCHEDELIC DRUGS MARKET, BY REGIONAL, 2019 TO 2035 (USD Billions)




  143. BENCHMARKING OF MAJOR COMPETITORS




 

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
report-img
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.
Press Release
Category icon
Psychedelic Drugs Market is predicted to reach USD 8.6 billion at a CAGR of 14.20% during the for...
Logo
861332069 Dmca
Paypal new Ssl cf new
Services Syndicate Reports Category Intelligence News How To Order FAQs
Our Company About US Careers Contact Us Terms & Conditions Privacy Policy
Banking Partners Paymentoptions
ISO Certifications
Iso new
✉  info@marketresearchfuture.com
📞  +1 (855) 661-4441(US)
📞  +44 1720 412 167(UK)
📞  +91 2269738890(APAC)

© 2025 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)